portion reproduce respiratory syndrome per economy devant disease pig caps virus prev arteriviru highly mutant rna wide use modify live vaccine fail prevent outbreak infect more safety question though poorly immunogen inactive vaccine safe infect primarily lung macrophages therefore attempt strengthen immunogen inactivatedkil antigen kg respect pig system entra biodegrad polylacticcoglycol acid nanoparticles nymag couple potent mucosa adj whole cell last mycobacterium tuberculosis tb wcl deli formal twice entrants grow previous shown single dose partial clear challenge heterolog recent report couple unentrap significantly viremia since goal studi investing viral load various immune correct protect surface parenchyma vaccine prrsvchalleng result india five differ vaccineadjuv formal combine detect replica infect tenfor reduce lung assoc substantial reduce gross microscopy pathology immunology strong humor enhance neutral tier high avid antibody cellmedi response augment popup interferonÎ³ secret cd lymphocyte secret immunosuppress cytokine observe concur soluble elicit broadly crossprotect antiprrsv immune 